73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainMultiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibo

Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainMultiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibo
Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma

Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma
Model suggests increased use of Paxlovid could cut hospitalizations, deaths and costs

Model suggests increased use of Paxlovid could cut hospitalizations, deaths and costs

by University of Texas at AustinEpidemiology researchers have found that if just 20% of symptomatic COVID cases was treated with Paxlovid, it would reduce deaths, hospitalizations and costs. Cred

Model suggests increased use of Paxlovid could cut hospitalizations, deaths and costs

by University of Texas at AustinEpidemiology researchers have found that if just 20% of symptomatic COVID cases was treated with Paxlovid, it would reduce deaths, hospitalizations and costs. Cred
Study finds cancer cells use a new fuel in absence of sugar

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ
Remote dietary intervention feasible, may reduce chronic fatigue for lymphoma survivors

Remote dietary intervention feasible, may reduce chronic fatigue for lymphoma survivors

by Ohio State University Medical CenterRegistered dietitian Anna Maria Bittoni meets virtually with a cancer survivor to explain the benefits of different foods. The pilot study at The Ohio State

Remote dietary intervention feasible, may reduce chronic fatigue for lymphoma survivors

by Ohio State University Medical CenterRegistered dietitian Anna Maria Bittoni meets virtually with a cancer survivor to explain the benefits of different foods. The pilot study at The Ohio State
Researchers map the effects of all potential changes in key cancer gene

Researchers map the effects of all potential changes in key cancer gene

byThe Francis Crick InstituteFunction scores capture fitness effects mediated at both the transcript and protein 457 level. Credit: Megan Buckley et alResearchers at the Francis Crick Institute

Researchers map the effects of all potential changes in key cancer gene

byThe Francis Crick InstituteFunction scores capture fitness effects mediated at both the transcript and protein 457 level. Credit: Megan Buckley et alResearchers at the Francis Crick Institute
To rev-up CAR T-cell therapy, inhibit the SUSD2 membrane protein, study suggests

To rev-up CAR T-cell therapy, inhibit the SUSD2 membrane protein, study suggests

byOhio State University Medical CenterCredit: Pixabay/CC0 Public DomainInhibiting a particular protein in cancer-killing immune cells might improve the long-term effectiveness of CAR T-cell and

To rev-up CAR T-cell therapy, inhibit the SUSD2 membrane protein, study suggests

byOhio State University Medical CenterCredit: Pixabay/CC0 Public DomainInhibiting a particular protein in cancer-killing immune cells might improve the long-term effectiveness of CAR T-cell and
Cancer metastasis: Tumor plasticity counts

Cancer metastasis: Tumor plasticity counts

by Université libre de BruxellesCredit: CC0 Public DomainCancer metastasis, which is the propagation of tumor cells into distant organs, is the leading cause of cancer patient mortality. To under

Cancer metastasis: Tumor plasticity counts

by Université libre de BruxellesCredit: CC0 Public DomainCancer metastasis, which is the propagation of tumor cells into distant organs, is the leading cause of cancer patient mortality. To under
Study highlights the importance of infection prevention after CAR T-cell therapy

Study highlights the importance of infection prevention after CAR T-cell therapy

Study highlights the importance of infection prevention after CAR T-cell therapybyDana-Farber Cancer InstituteDistribution of causes of nonrelapse deaths across treatment settings and disease en

Study highlights the importance of infection prevention after CAR T-cell therapy

Study highlights the importance of infection prevention after CAR T-cell therapybyDana-Farber Cancer InstituteDistribution of causes of nonrelapse deaths across treatment settings and disease en
New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s
Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

by National University of SingaporePotential new therapeutic targets in NKTL. Credit: Dr Jianbiao ZhouA team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the N

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

by National University of SingaporePotential new therapeutic targets in NKTL. Credit: Dr Jianbiao ZhouA team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the N
Exploring better care for pregnant women with precancerous cervical cancer

Exploring better care for pregnant women with precancerous cervical cancer

by Medizinische Hochschule HannoverMethylation levels of FAM19A4 (A) and miR124-2 (B) for the different groups of pregnant women. Credit:International Journal of Cancer(2022). DOI: 10.1002

Exploring better care for pregnant women with precancerous cervical cancer

by Medizinische Hochschule HannoverMethylation levels of FAM19A4 (A) and miR124-2 (B) for the different groups of pregnant women. Credit:International Journal of Cancer(2022). DOI: 10.1002